Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.

Mowry CJ, Alonso C, Iruarrizaga-Lejarreta M, Ortiz P, Levitsky J, Rinella M. Transplant Direct. 2021 Nov 5;7(12):e784. doi: 10.1097/TXD.0000000000001227.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?